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ABSTRACT 
The prevalence of psychiatric symptoms ranges from 17-44% in intensive care unit (ICU) 
survivors. The relationship between the comorbidity of psychiatric symptoms and quality of life 
(QoL) in ICU survivors has not been carefully examined. This study examined the relationship 
between psychiatric comorbidities and QoL in 58 survivors of ICU delirium. Patients completed 
three psychiatric screens at three months after discharge from the hospital: the Patient Health 
Questionnaire (PHQ-9) for depression, the Generalized Anxiety Disorder-7 (GAD-7) for anxiety, 
and the Post-Traumatic Stress Syndrome (PTSS-10) for PTSD. Patients with 3 positive screens 
(PHQ-9 ≥ 10, GAD-7 ≥ 10, and PTSS-10 > 35) comprised the high psychiatric comorbidity 
group. Patients with 1-2 positive screens were defined as the low to moderate psychiatric 
comorbidity group. Patients with 3 negative screens were defined as the no psychiatric 
morbidity group. 31% of patients met the criteria for high psychiatric comorbidity. After adjusting 
for age, gender, Charlson Comorbidity Index, discharge status, prior history of depression and  
anxiety, patients who had high psychiatric comorbidity were more likely to have a poorer QoL 
compared to the low to moderate comorbidity and no morbidity groups, as measured by a lower 
EQ-5D-3L Index (no = 0.69 ± 0.25, low-moderate = 0.70 ± 0.19, high = 0.48 ± 0.24; P = 0.017). 
Future studies should confirm these findings and examine whether survivors of ICU delirium 
with high psychiatric comorbidity have different treatment needs from survivors with lower 
psychiatric comorbidity. 
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INTRODUCTION 
The prevalence of depression, anxiety, and post-traumatic stress disorder (PTSD) symptoms in 
ICU survivors ranges from 17-44%.1-4 Psychiatric comorbidity, the presence of two or more 
psychiatric disorders, is highly prevalent in survivors of acute respiratory distress syndrome and 
is associated with higher mortality in post-surgical ICU survivors.5-7 While long-term cognitive 
impairment in patients with ICU delirium has been associated with poor quality of life (QoL),1 the 
effects of psychiatric comorbidity on QoL among similar patients are not as well understood. In 
this study, we examined whether psychiatric comorbidity was associated with poorer QoL in 
survivors of ICU delirium. 
 
METHODS 
We examined subjects who participated in the Pharmacologic Management of Delirium (PMD) 
clinical trial. This trial examined the efficacy of a pharmacological intervention for patients who 
developed ICU delirium at a local tertiary care academic hospital.8 Out of 62 patients who 
participated in the follow-up of the PMD study, 58 completed Quality of Life interviews and 
validated psychiatric screens (Patient Health Questionnaire (PHQ-9) for depression, the 
Generalized Anxiety Disorder-7 (GAD-7) for anxiety, and the Post-Traumatic Stress Syndrome 
(PTSS-10) Scale for PTSD) at three months after hospital discharge. High psychiatric 
comorbidity was defined as significant symptoms for all three conditions (depression: PHQ-9 
score ≥ 10, anxiety: GAD-7 ≥ 10, and PTSD: PTSS-10 > 35). No significant symptoms for all 
three conditions was defined as no psychiatric morbidity.  Significant symptoms for 1-2 
conditions were defined as low-moderate psychiatric comorbidity. 
 
Participants also completed two complementary QoL measures, the EQ-5D-3L Index and the 
EQ-5D-Visual Analog Scale (EQ-5D-VAS).9 The EQ-5D-3L Index asks participants to rate 
themselves as having 1: no problems, 2: some problems or 3: extreme problems on five scales: 
mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. The scores are then 
indexed against the U.S. population to create a continuous index scale ranging from -0.11 to 
1.00.  A score of 1 represents perfect health, 0 represents death and negative values indicate a 
health state worse than death.  The EQ-5D-VAS asks participants to draw a line on a visual 
scale from an anchor box to the point that represents their health state. The score ranges from 0 
being worst imaginable health state to 100 being best imaginable health state. Demographic, 
clinical characteristics, and prior history of depression, anxiety, and PTSD were obtained 
through PMD study records and clinical records. The Charlson Comorbidity Index, which 
measures chronic co-morbidities, and APACHE II, which estimates acute severity of illness 
within 24 hours of ICU admission, were calculated from patients’ available clinical information. 
 
Fisher’s exact tests were used to compare dichotomous outcomes. ANOVA was used to 
compare continuous outcomes across the 3 psychiatric groups. ANCOVA was used to 
determine whether psychiatric comorbidity in survivors of ICU delirium was associated with QoL 
measures. Models were adjusted for the following covariates: age, gender, Charlson 
Comorbidity Index, discharged to home, prior history of depression, and prior history of anxiety. 
To assess the relationship of psychiatric comorbidity with QoL, we chose the two continuous 
QoL measures as the outcome since we were interested in the effect of psychiatric burden on 
QoL Therefore we used ANCOVA with QoL as the dependent variable and psychiatric burden 
as an independent variable.  Pairwise comparisons were then performed when overall 
differences were significant (P < 0.05). We performed two separate sensitivity analyses. The 
first analysis looked solely at the subgroup of patients from the MICU.  We also recalculated the 
EQ-5D-3L index excluding the anxiety/depression item.  
 
RESULTS 
Nearly one-third of patients (18/58) had high psychiatric burden. Table 1 compares the 
demographic and clinical characteristics of patients with high psychiatric comorbidity with those 
of low to moderate psychiatric comorbidity and with no psychiatric morbidity. Patient groups did 
not differ significantly in terms of demographics. For clinical characteristics, patients with high 
psychiatric comorbidity were more likely than patients with low to moderate psychiatric 
comorbidity to have a prior history of depression (P < 0.05). 
 
Patients with high psychiatric comorbidity were more likely to have a poorer QoL when 
compared to patients with low to moderate psychiatric comorbidity and with no morbidity, as 
measured by a lower EQ-5D-3L Index (no = 0.69 ± 0.25, low-moderate = 0.70 ± 0.19, high = 
0.48 ± 0.24; P = 0.006) and EQ-5D-VAS (no = 67.0 ± 20.7, low-moderate 76.6 ± 20.0, high = 
50.8 ± 22.4; P = 0.004). After adjustment for covariates, patients with high psychiatric 
comorbidity had a poorer quality of life compared to those with no morbidity or low to moderate 
comorbidity on the EQ-5D-3L Index (P = 0.017 for overall differences), whereas patients who 
had high psychiatric comorbidity had poorer quality of life compared to those with low to 
moderate comorbidity on the EQ-5D-VAS (P = 0.039 for overall differences) (Figure 1).  
Subgroup analysis of MICU patients yielded similar results. Patients with high psychiatric 
burden had significantly poorer quality of life as measured by the EQ-5D-3L (unadjusted 
p=0.044, adjusted p=0.003) and the EQ-VAS (unadjusted p=0.007 adjusted p=0.021).  After 
excluding the anxiety/depression item from the EQ-5D-3L, we observed similar differences (no 
= 0.71 ± 0.24, low-moderate = 0.75 ± 0.15, high = 0.58 ± 0.22; unadjusted P = 0.062; adjusted 
P= 0.040). 
   
DISCUSSION/CONCLUSION 
Psychiatric comorbidities in ICU survivors are common and pose a significant clinical issue. 
Patients with multiple psychiatric comorbidities can be more complicated to identify from a 
diagnostic standpoint and often require more prolonged, intensive mental health treatment 
compared to patients with a single psychiatric disorder.10,11 Our study showed that high 
psychiatric comorbidity in survivors of ICU delirium is associated with a decreased QoL 
compared to those with no psychiatric comorbidity or with low to moderate psychiatric 
comorbidities. This finding is consistent with previous studies in the general population that 
patients with multiple psychiatric comorbidities are associated with a poorer QoL compared to 
patients with single psychiatric comorbidity.10,11 
 
There is a pressing need to better characterize psychiatric comorbidities in ICU survivors 
because our current evidence suggests that the prevalence of psychiatric comorbidities of ICU 
survivors is substantially higher than that of the general population. We found that nearly a third 
of survivors of ICU delirium had comorbid depression, anxiety, and PTSD symptoms at three 
months. This is consistent with the few other studies in ICU survivors which showed a 
prevalence of psychiatric comorbidity of 25-33%.5,12 These rates are substantially higher than 
the prevalence in the general population of 6%.13 
 
The high rate of psychiatric comorbidities may render it difficult to effectively treat the mental 
health symptoms in ICU survivors”.14 Treating multiple psychiatric comorbidities may also be 
especially challenging in survivors of ICU delirium because they have a high prevalence of 
cognitive impairment. Mental health treatments for patients with psychiatric disorders and 
comorbid cognitive impairment are limited. Better characterization of psychiatric comorbidity in 
ICU survivors, particularly those with ICU delirium, is vital to the development of more effective, 
bundled treatments for this population with multiple comorbidities. 
 
Standardized screenings of ICU survivors at high risk for psychiatric disorders, such as 
survivors of ICU delirium, may help to identify patients with comorbid psychiatric disorder 
symptoms and have them referred to appropriate treatment earlier in hopes of improving their 
QoL sooner. Although opportunities to deliver integrated outpatient collaborative mental health 
and medical care for a subspecialty population are limited, one potential model of care would be 
to utilize a collaborative care model in an ICU survivor clinic.15 
 
Strengths of our study include the examination of psychiatric comorbidities in survivors of ICU 
delirium, who often have a poor QoL. A deeper understanding of psychiatric comorbidity and its 
relationship with quality of life (QoL) is needed to better understand how to deliver more 
effective treatments for these survivors. Limitations include the small sample size, a one-time 
measurement of psychiatric comorbidities at the 3 month follow-up based on screenings tools, 
and lack of objective measures of physical functioning to determine the effects of psychiatric 
comorbidities on physical functioning. There may also have been differences in how patients 
with no psychiatric comorbidity responded to the EQ-VAS due to premorbid differences (e.g. 
they were healthier prior to their ICU stay and perceived their survivor status more negatively). 
This may explain why we did not see a statistically significant difference between no psychiatric 
comorbidity and high psychiatric comorbidity groups on the EQ-5D-VAS. Nevertheless, we did 
see a difference between the low to moderate psychiatric comorbidity group on EQ-5D-VAS, 
and differences between the no comorbidity and low to moderate comorbidity groups versus the 
high comorbidity group on the EQ-5D-3L. Finally, data about psychiatric history and QoL prior to 
ICU hospitalization were limited. Therefore truly determining incidence versus prevalence of 
post-ICU comorbidities, and whether psychiatric symptoms and its effects of QoL were due to 
ICU hospitalization or premorbid psychiatric symptoms is difficult. 
 
Our study demonstrated that in survivors of ICU delirium, higher comorbidity of psychiatric 
symptoms was associated with poorer QoL. Future studies will need to confirm these findings. 
We will also need to identify potentially reversible risk factors for psychiatric comorbidity and 
poorer QoL, and develop treatments to effectively target the mental health symptoms of 
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Figure 1. Mean EQ-5D-3L Index or Mean EQ-5D-VAS Index Grouped by Psychiatric 
Comorbidities. 
Caption: 
ANCOVA models were adjusted for age, gender, Charlson comorbidity index, being discharged 
to home, prior history of depression, and prior history of anxiety. 
All P-values are after covariate adjustment. P = 0.017 for overall trend for EQ-5D-3L Index, and 
P = 0.039 for overall trend for EQ-5D-VAS. 
* P < 0.05 for pairwise comparison. 
 
 
